Scpharmaceuticals Drug Patent Portfolio
Scpharmaceuticals owns 2 orange book drugs protected by 14 US patents Given below is the list of Scpharmaceuticals's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11497755 | Concentrated Liquid Pharmaceutical Formulations Of Furosemide | 30 Jan, 2040 | Active |
| US11559535 | Concentrated Liquid Pharmaceutical Formulations Of Furosemide | 30 Jan, 2040 | Active |
| US11571434 | Concentrated Liquid Pharmaceutical Formulations Of Furosemide | 30 Jan, 2040 | Active |
| US11998555 | Concentrated Liquid Pharmaceutical Formulations Of Furosemide And Methods Of Administering The Same | 30 Jan, 2040 | Active |
| US12048709 | Concentrated Liquid Pharmaceutical Formulations Of Furosemide And Methods Of Administering The Same | 30 Jan, 2040 | Active |
| US12491193 | Concentrated Liquid Pharmaceutical Formulations Of Furosemide And Methods Of Administering The Same | 30 Jan, 2040 | Active |
| US12491194 | Concentrated Liquid Pharmaceutical Formulations Of Furosemide And Methods Of Administering The Same | 30 Jan, 2040 | Active |
| US12491195 | Concentrated Liquid Pharmaceutical Formulations Of Furosemide And Methods Of Administering The Same | 30 Jan, 2040 | Active |
| US12491196 | Concentrated Liquid Pharmaceutical Formulations Of Furosemide And Methods Of Administering The Same | 30 Jan, 2040 | Active |
| US12491197 | Concentrated Liquid Pharmaceutical Formulations Of Furosemide And Methods Of Administering The Same | 30 Jan, 2040 | Active |
| US10272064 | Pharmaceutical formulations for subcutaneous administration of furosemide | 03 Apr, 2034 | Active |
| US11433044 | Pharmaceutical formulations for subcutaneous administration of furosemide | 03 Apr, 2034 | Active |
| US12370168 | Pharmaceutical Formulations For Subcutaneous Administration Of Furosemide | 03 Apr, 2034 | Active |
| US9884039 | Pharmaceutical formulations for subcutaneous administration of furosemide | 03 Apr, 2034 | Active |
Latest Legal Activities on Scpharmaceuticals's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Scpharmaceuticals.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 06 Mar, 2026 | US11433044 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 17 Dec, 2025 | US12370168 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 17 Dec, 2025 | US9884039 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 17 Dec, 2025 | US11433044 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 17 Dec, 2025 | US10272064 |
| Recordation of Patent Grant Mailed | 05 Aug, 2025 | US12370168 |
| Patent Issue Date Used in PTA Calculation | 29 Jul, 2025 | US12370168 |
| Patent eGrant Notification | 29 Jul, 2025 | US12370168 |
| Recordation of Patent eGrant | 29 Jul, 2025 | US12370168 |
| Email Notification | 29 Jul, 2025 | US12370168 |
| Mail Patent eGrant Notification | 29 Jul, 2025 | US12370168 |
| Email Notification | 17 Jul, 2025 | US12370168 |
| Issue Notification Mailed | 16 Jul, 2025 | US12370168 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 15 Jul, 2025 | US9884039 |
| Dispatch to FDC | 26 Jun, 2025 | US12370168 |
Scpharmaceuticals's Family Patents
Scpharmaceuticals drugs have patent protection in a total of 15 countries. It's US patent count contributes only to 25.0% of its total global patent coverage. Click
below to unlock the full patent family tree.
Scpharmaceuticals Drug List
Given below is the complete list of Scpharmaceuticals's drugs and the patents protecting them.
1. Furoscix
Furoscix is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10272064 | Pharmaceutical formulations for subcutaneous administration of furosemide |
03 Apr, 2034
(7 years from now)
| Active |
| US11433044 | Pharmaceutical formulations for subcutaneous administration of furosemide |
03 Apr, 2034
(7 years from now)
| Active |
| US12370168 | Pharmaceutical Formulations For Subcutaneous Administration Of Furosemide |
03 Apr, 2034
(7 years from now)
| Active |
| US9884039 | Pharmaceutical formulations for subcutaneous administration of furosemide |
03 Apr, 2034
(7 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Furoscix's drug page
2. Furoscix Readyflow (autoinjector)
Furoscix Readyflow (autoinjector) is protected by 10 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11497755 | Concentrated Liquid Pharmaceutical Formulations Of Furosemide |
30 Jan, 2040
(13 years from now)
| Active |
| US11559535 | Concentrated Liquid Pharmaceutical Formulations Of Furosemide |
30 Jan, 2040
(13 years from now)
| Active |
| US11571434 | Concentrated Liquid Pharmaceutical Formulations Of Furosemide |
30 Jan, 2040
(13 years from now)
| Active |
| US11998555 | Concentrated Liquid Pharmaceutical Formulations Of Furosemide And Methods Of Administering The Same |
30 Jan, 2040
(13 years from now)
| Active |
| US12048709 | Concentrated Liquid Pharmaceutical Formulations Of Furosemide And Methods Of Administering The Same |
30 Jan, 2040
(13 years from now)
| Active |
| US12491193 | Concentrated Liquid Pharmaceutical Formulations Of Furosemide And Methods Of Administering The Same |
30 Jan, 2040
(13 years from now)
| Active |
| US12491194 | Concentrated Liquid Pharmaceutical Formulations Of Furosemide And Methods Of Administering The Same |
30 Jan, 2040
(13 years from now)
| Active |
| US12491195 | Concentrated Liquid Pharmaceutical Formulations Of Furosemide And Methods Of Administering The Same |
30 Jan, 2040
(13 years from now)
| Active |
| US12491196 | Concentrated Liquid Pharmaceutical Formulations Of Furosemide And Methods Of Administering The Same |
30 Jan, 2040
(13 years from now)
| Active |
| US12491197 | Concentrated Liquid Pharmaceutical Formulations Of Furosemide And Methods Of Administering The Same |
30 Jan, 2040
(13 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Furoscix Readyflow (autoinjector)'s drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List